返回 Agenda
Session 4: The IND in Detail - Modules 4, 5, and 2
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
- IND Item 8: Nonclinical Pharmacology and Toxicology
- IND Item 9: Previous Human Experience
- IND Item 10: Additional Information